Table 1.
Patient characteristics
| Number | 83 |
|---|---|
| Age, mean (range) | 61 (21–82) |
| Sex, male (%) | 42 (51) |
| BMI, mean (SD) | 30.0 (5.5) |
| Atopy, n (%) | 61 (73) |
| Ex-smoker, n (%) | 34 (41) |
| Pack years, median (q1,q3) | 26 (2,40) |
| FEV1 % predicted, mean (SD) | 72.2 (20.3) |
| FEV1/FVC, mean (SD) | 0.66 (0.12) |
| GINA treatment step n (%) | |
| 3 | 14 (17) |
| 4 | 67 (81) |
| 5 | 2 (2) |
| ACQ6, mean (SD) | 1.83 (0.82) |
| ICS dose μg, median (q1,q3) | 1000 (800,2000) |
| Taking regular OCS, n (%) | 3 (4) |
| Sputum eosinophils %, median (q1,q3) | 2.1 (0.5,9.5) |
| Blood eosinophils, x109/mL, median (q1,q3), n = 67 | 0.23 (0.11, 0.40) |
BMI body mass index, ACQ6 Asthma Control Questionnaire 6, ICS inhaled corticosteroid dose (in CFC beclomethasone equivalents), OCS oral corticosteroids